logo
Plus   Neg
Share
Email

Nokia Introduces Two New Mobile Phone Models - Quick Facts

Nokia Corp. (NOK) unveiled two new mobile phone models as it continues to speed up its strategy to connect the next billion consumers to information and the internet. The Nokia 110 and Nokia 112 have been designed to appeal to young, urban consumers who want to experience a fast, affordable online experience, the company said.

According to the company, both devices are perfect for communicating across Facebook, Twitter and social media networks. This innovative technology allows users to consume less data by up to 90%, by compressing websites in the cloud. Both devices offer direct access to Facebook and Twitter from their home screens. The Nokia 112 also features preloaded eBuddy instant messaging service right out of the box, so users can use popular chat services to keep conversations going 24/7.

Besides, Nokia 110 and Nokia 112 are both Dual SIM phones, featuring the benefits of Nokia's unique and industry leading Easy Swap technology. This enables users to switch between SIMs quickly without having to remove their battery or turn off their phone. The Easy Swap technology can personalize and remember up to five different SIM cards, giving consumers full control over their costs.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT